EUVIMEDEUVIMED entdecken
Open Access

Dual Sensitization Enables Synergistic Photodynamic Therapy and Radiotherapy for Breast Cancer

Yingying Zhang, Shaoqing Chen, Chun Liu, Pengyin Li, Yutao Zhang, Ziman Li, Xinye Ni iD

Research · 01.01.2026 · 9

DOI: 10.34133/research.1114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research, online erschienen am 06.02.2026. Verfasst von Yingying Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Second People's Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University; Jiangsu Province Engineering Research Center …. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Changzhou Social Development Project.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy (RT) and photodynamic therapy (PDT) for breast cancer are limited by tumor hypoxia and suboptimal photosensitizer performance. We developed folate-modified copper-doped carbon dots and loaded them with 5-aminolevulinic acid (ALA) to yield FCA, a nanoplatform that executes cascade nanozyme activities to remodel the tumor microenvironment: decomposing H 2 O 2 to relieve hypoxia, generating hydroxyl radicals and singlet oxygen ( 1 O 2 ), and depleting glutathione (GSH). This priming enabled efficient ALA-to-protoporphyrin IX conversion, which subsequently amplified reactive oxygen species generation. The elevated oxidative stress then synergized with RT to accumulate DNA double-strand breaks and trigger cell cycle arrest. Consequently, FCA-PDT-RT reduced 4T1 cell viability to 20.09% and induced 83.82% apoptosis outcomes mechanistically linked to nuclear factor erythroid 2-related factor 2 (NRF2)–Kelch-like ECH-associated protein 1 (KEAP1)–heme oxygenase 1 (HMOX1) pathway activation. Despite compensatory upregulation of antioxidant genes (HMOX1 and glutamate–cysteine ligase modifier subunit [GCLM]), intracellular GSH and adenosine triphosphate were severely depleted, establishing a metabolic crisis wherein synthesis could not match consumption. This redox/energy collapse drove the pronounced cytotoxicity observed. In an orthotopic 4T1 model, FCA-PDT-RT achieved superior tumor control at only 12 Gy, which correlated with increased CD3 + /CD8 + T cell infiltration and suppressed angiogenesis, while maintaining favorable safety. FCA thus enables synergistic PDT-RT through sequential microenvironment remodeling, oxidative amplification, and metabolic exhaustion, offering a dose-sparing strategy with translational promise for breast cancer therapy.

Autor:innen und Institutionen

  • The Second People's Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University; Jiangsu Province Engineering Research Center of Medical Physics; Medical Physics Research Center, Nanjing Medical U…
  • School of Pharmacy, Changzhou University, Jiangsu, Changzhou, 213164, China.

ORCID-Profile: Xinye Ni

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Changzhou Social Development Project
  • Changzhou Applied Basic Research Program Project
  • General Project of Jiangsu Provincial Health Commission
  • Jiangsu Provincial Medical Key Discipline Construction Unit (Oncology Therapeutics

Zitieren

APA

Zhang, Y., Chen, S., Liu, C., Li, P., Zhang, Y., Li, Z., & Ni, X. (2026). Dual Sensitization Enables Synergistic Photodynamic Therapy and Radiotherapy for Breast Cancer. Research, 9. https://doi.org/10.34133/research.1114

Vancouver

Zhang Y, Chen S, Liu C, Li P, Zhang Y, Li Z, et al. Dual Sensitization Enables Synergistic Photodynamic Therapy and Radiotherapy for Breast Cancer. Research. 2026;9. doi:10.34133/research.1114

BibTeX
@article{Zhang2026,
  author = {Zhang, Yingying and Chen, Shaoqing and Liu, Chun and Li, Pengyin and Zhang, Yutao and Li, Ziman and Ni, Xinye},
  title = {Dual Sensitization Enables Synergistic Photodynamic Therapy and Radiotherapy for Breast Cancer},
  journal = {Research},
  year = {2026},
  volume = {9},
  doi = {10.34133/research.1114}
}
Kostenlos starten →